In a market where concentration risk is a growing concern for investors, considering value-oriented investments could be a strategic move. Avantis Investors chief investment strategist, Phil McInnis, believes in a more diversified approach beyond just looking at index funds like the S&P 500. He advocates for their exchange-traded fund strategy, which focuses on companies with
Air pollution is not just an environmental concern, but a looming threat to human health, especially for expectant mothers. Recent studies have brought to light the concerning link between maternal exposure to particulate matter (PM) and adverse pregnancy outcomes, particularly in relation to blood pressure complications. As we navigate through a world grappling with pollution
The impact of our body’s circadian clock goes beyond just regulating sleepiness and metabolism – recent research suggests that it may also affect the effectiveness of certain cancer treatments. Checkpoint inhibitors, which are immunotherapy drugs designed to enhance the immune system’s ability to recognize and fight cancer cells, have shown promise in treating various types
The study conducted by Dr. Erminia Massarelli focused on evaluating the combination of osimertinib and consolidative stereotactic ablative radiation (SABR) for the treatment of advanced EGFR-mutant non-small cell lung cancer (NSCLC). This study was carried out in collaboration with UT Southwestern and included 43 untreated patients with metastatic and incurable disease. The results of the